Oppenheimer Asset Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
DM
Oppenheimer Asset Management's NEO Position: Q3 2025 in Review
Oppenheimer Asset Management sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 18,276 shares — an estimated $134K sold.
Oppenheimer Asset Management first reported a position in NEO in Q1 2017 and held it in 25 quarters. The position peaked at $1.35M in Q4 2020. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.
- Oppenheimer Asset Management reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
- Oppenheimer Asset Management sold 18,276 NeoGenomics shares in Q3 2025, an estimated $134K.
- Oppenheimer Asset Management first reported a position in NeoGenomics in Q1 2017 and held it in 25 quarters.
- Oppenheimer Asset Management's NeoGenomics position peaked at $1.35M in Q4 2020.
- 254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.
Based on Oppenheimer Asset Management's 13F filing for Q3 2025, filed 6 Nov 2025.